NEW YORK (GenomeWeb News) – Olink and researchers from Uppsala University in Sweden have formed a new firm, called Olink Genomics, with the goal of commercializing technology for sample-preparation applications in the next-generation sequencing market, Olink said yesterday.
 
The new subsidiary of Olink intends to launch the Selector Technology, which researchers from Olink and Uppsala have developed for sequence-selective sample prep. Olink said that the technology would be rolled out as a service and as reagent kits.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.